Endovascular Therapies in Acute Ischemic Stroke

Diogo C. Haussen; Dileep R. Yavagal

doi:10.1055/s-0033-1364219

Seminars in Neurology, Inhaltsverzeichnis

Semin Neurol 2013; 33(05): 441-447
DOI: 10.1055/s-0033-1364219

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Endovascular Therapies in Acute Ischemic Stroke

Diogo C. Haussen

¹Department of Neurology and Neurosurgery, University of Miami Miller School of Medicine / Jackson Memorial Hospital, Miami, Florida.

,

Dileep R. Yavagal

¹Department of Neurology and Neurosurgery, University of Miami Miller School of Medicine / Jackson Memorial Hospital, Miami, Florida.

› Institutsangaben

Abstract

Intraarterial therapy for acute ischemic stroke (AIS) was originally described five decades ago. Since then, the endovascular management of AIS endovascular therapy has advanced swiftly, and a promising body of evidence informing patient selection and interventional techniques has accrued. The authors discuss the evolution of endovascular therapy for AIS, including a review of recently published landmark clinical trials.

Keywords

stroke - endovascular procedures - thrombectomy - randomized controlled trials

Volltext

Referenzen

References
1 Johnson HC, Walker AE. The angiographic diagnosis of spontaneous thrombosis of the internal and common carotid arteries. J Neurosurg 1951; 8 (6) 631-659
2 Feiring EH. Spontaneous occlusion of the internal carotid artery. Neurology 1954; 4 (6) 405-421
3 Feiring EH, Sussman BJ. Spontaneous occlusion of the middle cerebral artery. Neurology 1956; 6 (8) 529-546
4 Strully KJ, Hurwitt ES, Blankenberg HW. Thrombo-endarterectomy for thrombosis of the internal carotid artery in the neck. J Neurosurg 1953; 10 (5) 474-482
5 Sussman BJ, Fitch TS. Thrombolysis with fibrinolysin in cerebral arterial occlusion. J Am Med Assoc 1958; 167 (14) 1705-1709
6 del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998; 29 (1) 4-11
7 Furlan A, Higashida R, Wechsler L , et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999; 282 (21) 2003-2011
8 Saver JL, Liebeskind DS, Nogueira RG , et al. Need to clarify thrombolysis in myocardial ischemia (TIMI) scale scoring method in the Penumbra Pivotal Stroke Trial. Stroke 2010; 41: e115-e116
9 Tomsick T. TIMI, TIBI, TICI: I came, I saw, I got confused. AJNR Am J Neuroradiol 2007; 28: 382-84
10 Zaidat OO, Yoo AJ, Khatri P , et al. Recommendations on Angiographic Revascularization Grading Standards for Acute Ischemic Stroke: A consensus statement. Stroke 2013; 44 (9) 2650-2663
11 Barnwell SL, Clark WM, Nguyen TT, O'Neill OR, Wynn ML, Coull BM. Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. AJNR Am J Neuroradiol 1994; 15 (10) 1817-1822
12 Pierot L, Gralla J, Cognard C, White P. Mechanical thrombectomy after IMS III, synthesis, and MR-RESCUE. AJNR Am J Neuroradiol 2013; 34 (9) 1671-1673
13 Nakano S, Iseda T, Yoneyama T, Kawano H, Wakisaka S. Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion: an alternative option to intra-arterial thrombolysis. Stroke 2002; 33 (12) 2872-2876
14 Mahon BR, Nesbit GM, Barnwell SL , et al. North American clinical experience with the EKOS MicroLysUS infusion catheter for the treatment of embolic stroke. AJNR Am J Neuroradiol 2003; 24 (3) 534-538
15 Gobin YP, Starkman S, Duckwiler GR , et al. MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke 2004; 35 (12) 2848-2854
16 Smith WS, Sung G, Starkman S , et al; MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005; 36 (7) 1432-1438
17 Smith WS, Sung G, Saver J , et al; Multi MERCI Investigators. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008; 39 (4) 1205-1212
18 Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009; 40 (8) 2761-2768
19 Levy EI, Ecker RD, Horowitz MB , et al. Stent-assisted intracranial recanalization for acute stroke: early results. Neurosurgery 2006; 58 (3) 458-463 , discussion 458–463
20 Gupta R, Vora NA, Horowitz MB , et al. Multimodal reperfusion therapy for acute ischemic stroke: factors predicting vessel recanalization. Stroke 2006; 37 (4) 986-990
21 Rohde S, Seckinger J, Hähnel S, Ringleb PA, Bendszus M, Hartmann M. Stent design lowers angiographic but not clinical adverse events in stenting of symptomatic intracranial stenosis - results of a single center study with 100 consecutive patients. Int J Stroke 2013; 8 (2) 87-94
22 Rohde S, Bösel J, Hacke W, Bendszus M. Stent retriever technology: concept, application and initial results. J Neurointerv Surg 2012; 4 (6) 455-458
23 Roth C, Papanagiotou P, Behnke S , et al. Stent-assisted mechanical recanalization for treatment of acute intracerebral artery occlusions. Stroke 2010; 41 (11) 2559-2567
24 Stampfl S, Hartmann M, Ringleb PA, Haehnel S, Bendszus M, Rohde S. Stent placement for flow restoration in acute ischemic stroke: a single-center experience with the Solitaire stent system. AJNR Am J Neuroradiol 2011; 32 (7) 1245-1248
25 Nogueira RG, Lutsep HL, Gupta R , et al; TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012; 380 (9849) 1231-1240
26 Saver JL, Jahan R, Levy EI , et al; SWIFT Trialists. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012; 380 (9849) 1241-1249
27 Turk AS, Spiotta A, Frei D , et al. Initial clinical experience with the ADAPT technique: A direct aspiration first pass technique for stroke thrombectomy. J Neurointerv Surg 2012; 4: 199-205
28 Broderick JP, Palesch YY, Demchuk AM , et al; Interventional Management of Stroke (IMS) III Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013; 368 (10) 893-903
29 Ciccone A, Valvassori L, Nichelatti M , et al; SYNTHESIS Expansion Investigators. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013; 368 (10) 904-913
30 Kidwell CS, Jahan R, Gornbein J , et al; MR RESCUE Investigators. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013; 368 (10) 914-923
31 Broderick JP. The IMS III Trial: What we have learned. Paper presented at: Seventh Annual Cerebrovascular Symposium; May 9–10, 2013; Seattle, WA
32 Pierot L, Söderman M, Bendszus M , et al. Statement of ESMINT and ESNR regarding recent trials evaluating the endovascular treatment at the acute stage of ischemic stroke. Neuroradiology 2013;
33 Kidwell CS, Jahan R, Alger JR , et al; for the MR RESCUE Investigators. Design and rationale of the Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy (MR RESCUE) Trial. Int J Stroke 2012;
34 Kidwell CS, Jahan R, Saver JL. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013; 368 (25) 2434-2435
35 Parsons MW, Albers GWMR. MR RESCUE: is the glass half-full or half-empty?. Stroke 2013; 44 (7) 2055-2057
36 Lansberg MG, Straka M, Kemp S , et al; DEFUSE 2 study investigators. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol 2012; 11 (10) 860-867
37 Yoo AJ, Chaudhry ZA, Nogueira RG , et al. Infarct volume is a pivotal biomarker after intra-arterial stroke therapy. Stroke 2012; 43 (5) 1323-1330
38 Parsons MW, Christensen S, McElduff P , et al; Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) Investigators. Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab 2010; 30 (6) 1214-1225
39 Hacke W, Kaste M, Fieschi C , et al; The European Cooperative Acute Stroke Study (ECASS). Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA 1995; 274 (13) 1017-1025
40 Multicentre Acute Stroke Trial–Italy (MAST-I) Group. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial—Italy (MAST-I) Group. Lancet 1995; 346 (8989) 1509-1514
41 Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333 (24) 1581-1587
42 The Multicenter Acute Stroke Trial–Europe Study Group. Thrombolytic therapy with streptokinase in acute ischemic stroke. The Multicenter Acute Stroke Trial—Europe Study Group. N Engl J Med 1996; 335 (3) 145-150
43 Goyal M, Swartz RH. Epistemology, parachutes, and “Yeah, but” interventional stroke trials. Stroke 2013; 44 (7) 2036-2038
44 Hacke W, Furlan AJ. (Here comes that) razors edge. Endovascular stroke therapy: the end, or only the beginning?. Int J Stroke 2013; 8 (5) 331-333
45 Liebeskind DS. Trials of endovascular therapies or collaterals?. Int J Stroke 2013; 8 (4) 258-259
46 Akins PT, Amar AP, Pakbaz RS, Fields JD ; on behalf of the SWIFT Investigators. Complications of Endovascular Treatment for Acute Stroke in the SWIFT Trial with Solitaire and Merci Devices. AJNR Am J Neuroradiol 2013; Sep 12. [Epub ahead of print]